Key statistics
On Friday, Marinomed Biotech AG (93Z:MUN) closed at 8.78, 219.27% above the 52 week low of 2.75 set on Aug 16, 2024.
52-week range
Open | 8.78 |
---|---|
High | 8.78 |
Low | 8.78 |
Bid | 8.96 |
Offer | 9.66 |
Previous close | 7.98 |
Average volume | 217.20 |
---|---|
Shares outstanding | 1.69m |
Free float | 1.16m |
P/E (TTM) | -- |
Market cap | 16.10m EUR |
EPS (TTM) | -4.46 EUR |
Data delayed at least 15 minutes, as of Nov 15 2024 07:13 GMT.
More ▼
Announcements
- EQS-Adhoc: Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors
- EQS-News: Marinomed Biotech AG publishes clinical data for decongestant Carragelose nasal spray in peer-reviewed International Journal of General Medicine
- EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
- EQS-Adhoc: Marinomed Biotech AG begins contract negotiations for the sale of the Carragelose portfolio
- EQS-News: Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
- EQS-NVR: Marinomed Biotech AG: Release according to Article 135, Section 1 BörseG with the objective of Europe-wide distribution
- EQS-News: Marinomed Biotech AG reports positive clinical results for unique Carragelose eye drops
- EQS-DD: Marinomed Biotech AG: Andreas Grassauer, buy
- EQS-DD: Marinomed Biotech AG: Eva Prieschl-Grassauer, buy
- EQS-DD: Marinomed Biotech AG: Simon Nebel, buy
More ▼